Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells

European Journal of Pharmacology

Volumn 686, Issue 1-3, 2012, Pages 116-123

  Kazama, Kyosuke ^a   Usui, Tatsuya ^a   Okada, Muneyoshi ^a   Hara, Yukio ^a   Yamawaki, Hideyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Adipocytokine; Inflammation; Reactive oxygen species; Signal transduction; Vascular smooth muscle cell

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OMENTIN; RECOMBINANT CYTOKINE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INFLAMMATION; INTRACELLULAR SIGNALING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA, THORACIC; CELL ADHESION; CYTOKINES; GPI-LINKED PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LECTINS; MALE; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84861640275     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.033     Document Type: Article

References (33)

1. T. Aizawa, H. Wei, J.M. Miano, J. Abe, B.C. Berk, and C. Yan Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells Circ. Res. 93 2003 406 413
2. Y. Arita, S. Kihara, N. Ouchi, K. Maeda, H. Kuriyama, Y. Okamoto, M. Kumada, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, I. Shimomura, M. Muraguchi, Y. Ohmoto, T. Funahashi, and Y. Matsuzawa Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell Circulation 105 2002 2893 2898
3. M. Bluher, M. Fasshauer, A. Tonjes, J. Kratzsch, M.R. Schon, and R. Paschke Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism Exp. Clin. Endocrinol. Diabetes 113 2005 534 537
4. M. Bluher, J.W. Bullen Jr., J.H. Lee, S. Kralisch, M. Fasshauer, N. Kloting, J. Niebauer, M.R. Schon, C.J. Williams, and C.S. Mantzoros Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training J. Clin. Endocrinol. Metab. 91 2006 2310 2316
5. G. Csanyi, W.R. Taylor, and P.J. Pagano NOX and inflammation in the vascular adventitia Free Radic. Biol. Med. 47 2009 1254 1266
6. G.W. De Keulenaer, R.W. Alexander, M. Ushio-Fukai, N. Ishizaka, and K.K. Griendling Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle Biochem. J. 329 Pt 3 1998 653 657
7. C.M. de Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, J. Pray, K. Ndubuizu, S. Patil, A. Schwartz, M. Kligman, S.K. Fried, D.W. Gong, A.R. Shuldiner, T.I. Pollin, and J.C. McLenithan Omentin plasma levels and gene expression are decreased in obesity Diabetes 56 2007 1655 1661
8. G. Deng, Y. Long, Y.R. Yu, and M.R. Li Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway Int. J. Obes. (Lond) 34 2010 165 171
9. K. Grote, I. Flach, M. Luchtefeld, E. Akin, S.M. Holland, H. Drexler, and B. Schieffer Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species Circ. Res. 92 2003 e80 e86
10. J.D. Lambeth, G. Cheng, R.S. Arnold, and W.A. Edens Novel homologs of gp91phox Trends Biochem. Sci. 25 2000 459 461
11. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
12. C. Lugnier Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents Pharmacol. Ther. 109 2006 366 398
13. Y. Motobayashi, Y. Izawa-Ishizawa, K. Ishizawa, S. Orino, K. Yamaguchi, K. Kawazoe, S. Hamano, K. Tsuchiya, S. Tomita, and T. Tamaki Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells Hypertens. Res. 32 2009 188 193
14. M. Mukohda, T. Morita, M. Okada, Y. Hara, and H. Yamawaki Long-term methylglyoxal treatment impairs smooth muscle contractility in organ-cultured rat mesenteric artery Pharmacol. Res. 65 2012 91 99
15. A.W. Orr, N.E. Hastings, B.R. Blackman, and B.R. Wamhoff Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis J. Vasc. Res. 47 2010 168 180
16. S. Phalitakul, M. Okada, Y. Hara, and H. Yamawaki Vaspin prevents TNF-alpha-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-kappaB and PKCtheta activation in cultured rat vascular smooth muscle cells Pharmacol. Res. 64 2011 493 500
17. S. Reuter, S.C. Gupta, M.M. Chaturvedi, and B.B. Aggarwal Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol. Med. 49 2010 1603 1616
18. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115 126
19. A. Schaffler, M. Neumeier, H. Herfarth, A. Furst, J. Scholmerich, and C. Buchler Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue Biochim. Biophys. Acta 1732 2005 96 102
20. B.K. Son, M. Akishita, K. Iijima, K. Kozaki, K. Maemura, M. Eto, and Y. Ouchi Adiponectin antagonizes stimulatory effect of tumor necrosis factor-alpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5′-monophosphate-activated protein kinase Endocrinology 149 2008 1646 1653
21. D. Sorescu, M.J. Somers, B. Lassegue, S. Grant, D.G. Harrison, and K.K. Griendling Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells Free Radic. Biol. Med. 30 2001 603 612
22. D. Sorescu, D. Weiss, B. Lassegue, R.E. Clempus, K. Szocs, G.P. Sorescu, L. Valppu, M.T. Quinn, J.D. Lambeth, J.D. Vega, W.R. Taylor, and K.K. Griendling Superoxide production and expression of nox family proteins in human atherosclerosis Circulation 105 2002 1429 1435
23. T. Takeuchi, Y. Adachi, Y. Ohtsuki, and M. Furihata Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease Med. Mol. Morphol. 40 2007 115 120
24. B.K. Tan, S. Pua, F. Syed, K.C. Lewandowski, J.P. O'Hare, and H.S. Randeva Decreased plasma omentin-1 levels in type 1 diabetes mellitus Diabet. Med. 25 2008 1254 1255
25. R.M. Touyz Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease Braz. J. Med. Biol. Res. 37 2004 1263 1273
26. T. Usui, H. Yamawaki, M. Kamibayashi, M. Okada, and Y. Hara CV-159, a unique dihydropyridine derivative, prevents TNF-induced inflammatory responses in human umbilical vein endothelial cells J. Pharmacol. Sci. 113 2010 182 191
27. 2 +/calmodulin antagonist CV-159 in cultured vascular smooth muscle cells J. Pharmacol. Sci. 113 2010 214 223
28. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
29. H. Yamawaki Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses Biol. Pharm. Bull. 34 2011 307 310
30. H. Yamawaki, N. Tsubaki, M. Mukohda, M. Okada, and Y. Hara Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels Biochem. Biophys. Res. Commun. 393 2010 668 672
31. H. Yamawaki, J. Kuramoto, S. Kameshima, T. Usui, M. Okada, and Y. Hara Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells Biochem. Biophys. Res. Commun. 408 2011 339 343
32. R.Z. Yang, M.J. Lee, H. Hu, J. Pray, H.B. Wu, B.C. Hansen, A.R. Shuldiner, S.K. Fried, J.C. McLenithan, and D.W. Gong Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am. J. Physiol. Endocrinol. Metab. 290 2006 E1253 E1261
33. T. Yoshimura, and J.J. Oppenheim Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties Exp. Cell Res. 317 2011 674 684